Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel computational tool for automated structure-based drug design

H J Böhm1

  • 1BASF AG, Central Research, Ludwigshafen, Germany.

Journal of Molecular Recognition : JMR
|September 1, 1993
PubMed
Summary

LUDI is a novel computer program for automated structure-based drug design. It rapidly generates and scores potential drug molecules by analyzing protein-ligand interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studying the deformation of arachnid slit sensilla by a fracture mechanical approach.

Journal of biomechanics·2005
Same author

Structure-based approaches in modern drug discovery research.

Ernst Schering Research Foundation workshop·2001
Same author

Structure-based library design: molecular modelling merges with combinatorial chemistry.

Current opinion in chemical biology·2000
Same author

Development of filter functions for protein-ligand docking.

Journal of molecular graphics & modelling·1999
Same author

Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors.

Journal of computer-aided molecular design·1999
Same author

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Journal of computer-aided molecular design·1998

Area of Science:

  • Computational chemistry
  • Biochemistry
  • Drug discovery

Background:

  • Structure-based drug design (SBDD) is crucial for developing new therapeutics.
  • Identifying novel ligands for target proteins requires efficient computational tools.
  • Existing methods may lack speed or comprehensive ligand generation capabilities.

Purpose of the Study:

  • To introduce LUDI, a computer program for automated structure-based drug design.
  • To enable the construction of novel ligands tailored to specific protein targets.
  • To facilitate rapid and interactive drug discovery workflows.

Main Methods:

  • LUDI utilizes rules derived from statistical analysis of organic molecule crystal packings.
  • It employs fragment-based docking into protein binding sites, optimizing interactions (hydrogen bonds, ionic, hydrophobic).
  • Ligands are constructed by appending fragments or linking multiple fragments via bridges, followed by scoring.

Main Results:

  • LUDI successfully constructs potential ligands for proteins with known 3D structures.
  • The program incorporates energetically favorable non-bonded contact geometries.
  • Ligands are scored using a function fitted to experimental binding constants.

Conclusions:

  • LUDI offers a fast and effective approach for automated structure-based drug design.
  • Its typical execution time of 1-5 minutes makes it suitable for interactive use.
  • This program can aid in identifying and optimizing lead compounds for drug development.

Related Experiment Videos